Patent ID: 11883525
Assignee: DOSE MEDICAL CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. An implant comprising:
axitinib, and
a bioerodible polyster polymer blend, comprising at least two polymers, wherein the bioerodible polyester polymer blend comprises an acid or ester end group polylactic acid (PLA) and an acid or ester end group poly-D,L-lactide-co-glycolide (PLGA), and wherein at least one of the two polymers comprises an ester end group,
wherein the ratio of PLA to PLGA is selected from a range of between about 10:1 to about 1:10, a range of between about 9:1 to about 1:9, a range of between about 8:1 to about 1:8, a range of between about 7:1 to about 1:7, a range of between about 6:1 to about 1:6, a range of between about 5:1 to about 1:5, or a range of between about 4:1 to about 1:4 and
wherein the axitinib is present in the implant in an amount selected from a range of between about 5 and about 80 percent (w/w).